The Case Comprehensive Cancer Center, an NCI designated comprehensive cancer center, is a partnership between Case Western Reserve University, University Hospitals of Cleveland and the Cleveland Clinic. It is a multi-disciplinary cancer research center, with 280 faculty members from twenty-seven departments distributed across six Schools and Colleges. Stanton L. Gerson, MD, directs the Center, which stimulates and coordinates basic and clinical cancer research across the institutions. Prioritization, regulatory compliance and quality assurance of clinical cancer research activities across the partner hospitals are ensured through a single protocol review process and a single cancer IRB. Over 1200 patients enter innovative clinical trials annually and over 7200 new patients are seen annually.
In 2004 $114 million in funding to the Center and its membership, largely from the National Institutes of Health, supports the cancer research program. Through the Center’s nine scientific programs and fourteen shared resource facilities, the Case Comprehensive Cancer Center continues to be successful in achieving its goals of improving the prevention, diagnosis and therapy of cancer through research; stimulating and supporting innovative, coordinated, interdisciplinary research on cancer etiology, diagnosis, treatment, and control; developing clinical applications of research discoveries that are made readily available to residents of Northeast Ohio through partnering hospitals; and developing cancer prevention and control activities that contribute to the reduction of cancer morbidity and mortality in the state of Ohio
.
|
